Pharmacological Therapies in Paroxysmal Nocturnal Haemoglobinuria: Focus on Complement Inhibition. [PDF]
DrugsKelly RJ, Holt M, Szer J.
europepmc +1 more source
Ravulizumab exposure in early pregnancy. [PDF]
Ann HematolFüreder W, Granser S, Repa A, Farr A.
europepmc +1 more source
Neonatal atypical hemolytic uremic syndrome from a factor H mutation treated with eculizumab
, 2015 Sheena Sharma +4 more
openalex +2 more sources
Eculizumab in C3 Glomerulopathy: A Systematic Review of Therapeutic Efficacy and Clinical Outcomes. [PDF]
PharmaceuticsLewandowski D +6 more
europepmc +1 more source
Response to: Eculizumab use throughout pregnancy in two patients with aquaporin‐4‐positive neuromyelitis optica spectrum disorder [PDF]
Ilya Kister, Alla Wilson
openalex +1 more source
Which Factors Influence Decisions to Withdraw from Eculizumab: A Qualitative Study of Patients Diagnosed with aHUS. [PDF]
PatientLecouturier J, Sheerin N.
europepmc +1 more source
The use of Eculizumab and Tocilizumab in the treatment of Hyperhemolysis syndrome, a comprehensive literature review. [PDF]
Front Med (Lausanne)Aqel A +6 more
europepmc +1 more source
Higher Doses of Eculizumab may be Beneficial in Paroxysmal Nocturnal Haemoglobinuria in Pregnancy. [PDF]
Eur J Case Rep Intern MedPatel HV +6 more
europepmc +1 more source
Gemcitabine-Induced Thrombotic Microangiopathy in a Patient With Metastatic Pancreatic Cancer: A Case Report. [PDF]
CureusYoung J.
europepmc +1 more source
Improved Iron Overload with Pegcetacoplan in Eculizumab-Experienced Patients with Paroxysmal Nocturnal Hemoglobinuria. [PDF]
Int J Mol SciShammo J +4 more
europepmc +1 more source